Hybridan Small Cap Feast

10 mins. to read
Hybridan Small Cap Feast

Joiners: Onward Opportunities Limited (ONWD.L) joins AIM. The Company’s investment objective is to generate returns for Shareholders through investments in equity and equity-related instruments of UK smaller companies that are predominantly listed or admitted to trading on markets operated by the LSE. The Company has conditionally raised Gross Proceeds of c.£12.8m of initial capital pursuant to the Placing at a price of 100 pence per Placing Share.

Leavers: No leavers today.

Banquet Buffet

Aquis Exchange 400p £110.1m (AQX.L)

The creator and facilitator of next-generation financial markets, announces its audited results for the year ended 31 December 2022. Net revenue increased 24% to £20.1m (FY21: £16.2m), while profit before tax increased 27% to £4.5m (FY21: £3.6m). Cash and cash equivalents at 31 December £14.2m (31 December 2021: £14.0m), with no debt held. During the period, Aquis launched Aquis Matching Pool (AMP). Membership grew to 41 (FY21: 38) and 22 new IPOs were delivered in 2022. Post perdio, the Company completed a rebrand in Q1 23, to reflect the diversification across three business units and four revenue streams. The Company is currently trading in line with expectations.

Caracal Gold 0.38p £7.0m (GCAT.L)

The expanding East African gold producer with over 1,300,000oz of JORC compliant gold resources, confirms ongoing delivery of high-grade ore from the high-grade zone in the Kilimapesa Hill deposit to the Milling plant. Ongoing 360tpd of high-grade material with average grades from 3.39g/t to 4.92g/t are being processed. The initial mining plan has been extended to over 180 days of delivery of high-grade material to the milling plant and exploration to define the full potential of the high-grade zone is ongoing. At the Milling plant the focus Is to increase the tonnage from 360tpd to 500tpd over the next few weeks.

Ebiquity 52.5p £63.2m (EBQ.L)

The media investment analysis Company, announces its results for the year ended 31 December 2022. Revenue increased 20% to £76m, in which 9% was organic growth. Acquisitions in the period contributed revenue of £6.8m. Adjusted operating profit increased by 98% to £9.3m. Statutory operating loss increased to £5.9m (2021: £5.1m). Net debt of £9.1m: cash balances of £12.4m and bank borrowings of £21.5m as at 31 December 2022 with undrawn bank facilities of £8.5m. Ebiquity won major new assignments including Shell, HSBC, Philips and Pepsico. The Company also announces the retirement of Chief Financial Officer and Chief Operating Officer, Alan Newman. Trading in the current year has started in line with the Board’s expectations.

Genedrive 34p £31.5m (GDR.L)

The point of care molecular diagnostics company, announces that, the UK’s National Institute for Health and Care Excellence (NICE) has ratified and finalised its recommendation that the Genedrive® MT-RNR1 ID Kit can be used by the NHS. The review was conducted through NICE’s Early Value Assessment (EVA) programme, which was designed to select and recommend new technologies that will make a real difference to patients and provide the most value for the NHS. The Genedrive® MT-RNR1 ID Kit can quickly and accurately identify babies with the MT-RNR1 genetic variant who may be at risk of hearing loss if given aminoglycoside antibiotics, and that no other test is available to provide results quickly enough to inform decisions on antibiotic prescribing in emergency care.

GETECH Group 14.63p £9.8m (GTC.L)

The geoenergy company and owner of hydrogen developer, H2 Green, announces that H2 Green’s Inverness Green Hydrogen Project has been selected for a £0.5m UK Government grant from its Net Zero Hydrogen Fund – Strand 1 Development Expenditure. H2 Green is developing a major green hydrogen hub in central Inverness, comprising green hydrogen production, storage and dispensing, and new onsite renewable energy generation. The grant will be used by H2 Green for development expenditure support for front-end engineering design (FEED) and post-FEED studies for the green hydrogen production facilities. H2 Green expects to immediately commence the project and draw down the grant in 2023. 

Gresham House 715p £273.7m (GHE.L)

The specialist alternative asset manager, announces its annual results for the year ended 31 December 2022. Assets under management (AUM) increased by 20% to £7.8bn, with organic growth of £1.1bn (17% growth). As a result, net core income gre 25% and operating profit increased 34%. At the end of the year, cash position of £32m and an undrawn committed Revolving Credit Facility of £20m available. A 19.3% Return on Capital Employed was generated,  in line with the 20.0% medium-term target, and has led to adjusted diluted Earnings Per Share increasing by 12% to 55.2p. As a result, the Board is recommending a 60% increase in the dividend to 16.0 pence. Throughout the period, funds were raised across all asset classes and international expansion continued with the acquisition of Burlington RE Property Management in Ireland.

Poolbeg Pharma* 7.95p £39.8m (POLB.L)

A biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, announces its audited results for the year ended 31 December 2022. During the period POLB 001 successfully completed the bacterial lipopolysaccharide human challenge trial in 2022. Results demonstrated POLB 001 to be safe and well tolerated and had a potent effect on systemic and localised inflammatory response in a dose dependent manner. In January 2023, the Company strategically expanded POLB 001 as a potential treatment option for Cytokine Release Syndrome, a side-effect associated with CAR T cell therapy. Clinical trial enabling activities are underway with trial initiation in CAR T cell patients expected in H1 2024. In its Artificial Intelligence (AI) Programmes (Respiratory Syncytial Virus AI programme and Influenza AI programme) unique disease progression data has been derived from human challenge trial samples. Poolbeg had £16.2m cash at year end.

Tasty 2.25p £3.3m (TAST.L)

The owner and operator of restaurants in the casual dining sector, announces its annual results for the 52 week period ended 25 December 2022. Revenue increased 26% to £44.0m (2021: £34.9m), however Adjusted EBITDA(post IFRS 16)  decreased to £2.6m (2021: £8.0m). Loss after tax for the period of £6.4m (post IFRS 16) (2021: £1.2m profit). As at 25 December 2022, the Group had an outstanding bank loan of £nil (2021: £1.25m) after repaying the Barclays Bank facility in full in June 2022. Cash at bank at the end of the period was £7.0m (2021: £11.0m). Capital investment increased to £1.6m (2021: £0.5m).  Performance to date is ahead of management expectations although, at this stage, it is difficult to predict the full extent of the cost of living crisis and input cost inflation and shortages.

Technology Minerals 0.98p £13.2m (TM1.L)

The UK company focused on creating a sustainable circular economy for battery metals, announces that its 48.25% owned battery recycling business, Recyclus Group Ltd (Recyclus), in collaboration with the University of Birmingham (UoB), has been awarded funding of £1.96m from the UK Government’s Innovate UK, to create a mobile battery recycling system capable of safely handling any type of lithium-ion (Li-ion) battery. Recyclus will lead the project and design and build a compact prototype Universal Battery Recycling System, a mobile recycling truck that handles a complete range of Li-ion battery modules from all areas of industry. The aim is to develop a consistent battery recycling channel which creates safe and environmentally friendly recycling of Li-ion batteries across the UK.

XLMedia 13.75p £35.7m (XLM.L)

A global digital media company, announces audited results for the year ended 31 December 2022. Following the decision to exit personal finance announced in December 2022, the Group’s FY 2022 results will be presented on a continuing operations basis. Revenue from continuing operations, including the benefit of 4 new US state launches, increased 24% to $71.8m, while Adjusted EBITDA from continuing operations was $17.8m up 18%, at a margin of 25%. Profit for the year from continuing operations decreased 14% to $2.4m. The core sport and gaming business delivered revenues of $69.6m, an increase of 27% and Adjusted EBITDA of $18.2m. Throughout the period, the Group continued to expand its presence in the US operating across all 19 regulated online sports states and restructured  the Group’s European Gaming and Sports division.

What’s cooking in the IPO kitchen?

Beacon Energy plc, intends to join the AIM market. In accordance with the Company’s strategy to focus on growth through acquisition or farm-in to oil and gas projects, the Company entered into the SPA with Tulip Oil Holdings B.V. In conjunction with the Acquisition, the Company has conditionally raised total gross proceeds of £6.04m which will be used to fund the drilling of the SCHB-2 development well onshore Germany and for working capital. Expected Admission date is 11 April 2023.

Ocean Harvest Technology Group plc, a commercial scale producers of seaweed blend ingredients for the animal feed market intends to join AIM. The main country of operation is Vietnam where the Company’s main production and processing facility is located. The Company is headquartered in Theale, UK with further operations in Galway, Ireland and Binh Duong Province, Vietnam. Admission delayed until 4th April 2023. 

M7 Box+ REIT plc, a newly established, externally managed closed-ended investment company announces that it intends to join the Wholesale segment of IPSX. Upon Admission, the Company proposes to acquire a portfolio of seven let and operational e-warehouses from M7 Box+ II LP. As at 31 December 2022, the Property Portfolio was valued at £228.9m. Expected Admission April 2023.

Altona Rare Earths, a mining company focused on the development of a significant Rare Earth Elements (REE) mining project in Africa, announced its intention of withdrawing from the AQSE Growth Market to the Standard Segment of the Main Market. The Company has just raised £2m and plans to use the proceeds to complete its maiden JORC compliant Mineral Resource Estimate and a Scoping Study for its Monte Muambe Rare Earths mining project in northwest Mozambique. Admission Delayed. A further update will be provided once the date of Admission, currently expected to be towards the end of March 2023, is confirmed.

Fadel Partners, a developer of cloud based brand compliance and rights and royalty management software, working with some of the world’s leading licensors and licensees across media, entertainment, publishing, consumer brands and hi-tech & gaming companies intends to join the AIM market. FADEL has two solutions, being IPM Suite and Brand Vision. Expected Admission late March 2023.

*A corporate client of Hybridan LLP

** Content not provided by Hybridan LLP

This document has been prepared by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor. The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document. This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU (“MIFID II Directive”); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook).

Comments (1)

Leave a Reply

Your email address will not be published. Required fields are marked *